THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 111 filers reported holding THERAVANCE BIOPHARMA INC in Q2 2021. The put-call ratio across all filers is 0.38 and the average weighting 0.1%.
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Madison Avenue Partners, LP | 7,012,226 | $71,104,000 | 15.26% |
Newtyn Management, LLC | 2,495,860 | $25,308,000 | 5.56% |
Chescapmanager LLC | 1,160,503 | $11,768,000 | 2.74% |
Baupost Group | 13,419,226 | $136,071,000 | 2.35% |
Weiss Asset Management LP | 7,457,060 | $75,615,000 | 1.86% |
Park West Asset Management LLC | 1,919,354 | $19,462,000 | 1.38% |
Cannon Global Investment Management, LLC | 65,000 | $659,000 | 1.06% |
Oasis Management Co Ltd. | 296,960 | $3,011,000 | 0.51% |
Rubric Capital Management LP | 356,100 | $3,611,000 | 0.18% |
Sagefield Capital LP | 51,600 | $523,000 | 0.17% |